Harada Shinpei

ハラダシンペイ | Harada Shinpei

Affiliation and department：
Papers (14)：

Koh Izumiyama, Tasuku Inao, Hideki Goto, Shinpei Harada, Hajime Senjo, Keito Suto, Junichi Hashiguchi, Reiki Ogasawara, Tomoyuki Saga, Tetsuyuki Igarashi, et al. Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group. Haematologica. 2024
Hajime Senjo, Shinpei Harada, Shimpei I Kubota, Yuki Tanaka, Takahiro Tateno, Zixuan Zhang, Satomi Okada, Xuanzhong Chen, Ryo Kikuchi, Naoki Miyashita, et al. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023
Xuanzhong Chen, Daigo Hashimoto, Ko Ebata, Shuichiro Takahashi, Yu Shimizu, Ryuga Shinozaki, Yuta Hasegawa, Ryo Kikuchi, Hajime Senjo, Kazuki Yoneda, et al. Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associated alteration of gut microbiota. Proceedings of the National Academy of Sciences of the United States of America. 2022. 119. 48. e2211230119
猪股百華, 中野恵一, 小林美穂, 大沼麗子, 山下亜妃子, 原田晋平, 吉田匠汰, 宮島徹, 渡邊千秋, 後藤秀樹, et al. 出血性膀胱炎において尿中ウイルス感染細胞が認められた同種造血幹細胞移植後の3症例. 日本臨床検査医学会誌. 2022. 70. 補冊. 222-222
泉山康, 稲尾翼, 後藤秀樹, 原田晋平, 千丈創, 須藤啓斗, 橋口淳一, 小笠原励起, 佐賀智之, 五十嵐哲祥, et al. DLBCLにおける適切なエンドポイントはEFS36である. 日本血液学会学術集会. 2022. 84回. 916-916

ｍore...

MISC (2)：

Awards (3)：

2024/07 - Japan society of hematology Best Poster Award (The 14th JSH International Symposium 2024) Intact Mitochondrial Transfer Enhances Anti-tumor Effects of CAR-T Cells
2023/12 - American society of hematology ASH Abstract Achievement Award Ferroptosis Inhibition Generates TCF-1+ CAR-T Cells with Enhanced Persistence and Cytotoxicity
2022/12 - American Society of Hematology ASH-JSH Abstract Achievement Award Intercellular Mitochondrial Transfer Enhances Metabolic Fitness and Anti-tumor Effects of CAR-T Cells

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page